comparemela.com

Latest Breaking News On - Orsay kang - Page 1 : comparemela.com

被严重低估的创新药潜力股?————东方财富网博客

被严重低估的创新药潜力股?————东方财富网博客
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

Beijing
China
Nanjing
Jiangsu
Chan
Jiangsu-orsay-kang
Orsay-kang
Nanjing-orsay-kang
Wei-switzerland
Kang-medical-science
Technology-limited

被严重低估的创新药潜力股?————东方财富网博客

被严重低估的创新药潜力股?————东方财富网博客
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

Beijing
China
Nanjing
Jiangsu
Chan
Jiangsu-orsay-kang
Orsay-kang
Nanjing-orsay-kang
Wei-switzerland
Kang-medical-science
Technology-limited

386股中报报喜 130股增长超1倍- CFi.CN 中财网

386股中报报喜 130股增长超1倍- CFi.CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.

Qixia
Fujian
China
Australia
Shanghai
Beijing
Czech-republic
Russia
Donghua
Sichuan
Sri-lanka
Nanjing

奥赛康上半年营收增长11% 5个新品获准上市 _ 东方财富网

奥赛康上半年营收增长11% 5个新品获准上市 _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

China
Romania
Orsay-kang
August-orsay-kang
Romania-division
Ai-division-omeprazole
August-orsay-kang-disclosure

奥赛康:上半年净利润同比增长15.39% 研发投入超2亿元 _ 东方财富网

8月29日晚间,奥赛康(002755)发布2021年半年度报告。报告期内,公司实现营业总收入167405万元,同比增长11.43%;实现归母净利润26317万元,同比增长15.39%;研发投入达到20661万元,占营业收入12.34%,重点聚焦小分子靶向创新药物、肿瘤免疫领域生物创新药研发。

China
Romania
Orsay-kang
Asia-pacific
Romania-division
Ai-division-omeprazole
Center-country
同比增长
奥赛康
研发
净利润
报告

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.